J. Siner

AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.

V. Arruda, Shangzhen Zhou, F. Mingozzi, 2015, Blood.

Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype.

M. Poncz, V. Arruda, Shangzhen Zhou, 2013, Blood.

Unexpected Role of PACE/Furin Cleavage Site in FVIII Biology: Implications for Hemophilia a Therapy

T. Nichols, V. Arruda, Shangzhen Zhou, 2014 .

Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A

V. Arruda, D. Sabatino, R. Camire, 2016, Journal of thrombosis and haemostasis : JTH.

Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.

T. Nichols, V. Arruda, R. Camire, 2016, JCI insight.

Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal model.

J. F. Wright, K. High, V. Arruda, 2011, Human gene therapy.

Cloning of an aquaporin homologue present in water channel containing endosomes of toad urinary bladder.

H. W. Harris, T. Hammond, K. Strange, 1996, The American journal of physiology.